U.S. hospitals to restrict Lilly COVID-19 antibody treatment due to limited supply – Reuters India

(Reuters) – U.S. hospitals, weighing high demand and tight supplies, said they may limit use of a new Eli Lilly and Co antibody drug to COVID-19 patients with multiple risk factors for serious illnes… [read more]

Leave a Comment